Third round table continues the dialogue on Long COVID
At the invitation of Federal Minister of Health Prof. Dr Karl Lauterbach, experts, patient advocacy groups and relevant public health stakeholders came together on 16 April 2024 in Berlin. The discussions focussed on the Federal Joint Committee’s (G-BA) new Long COVID directive, the promotion of patient-oriented research by the BMG, the planned measures to improve care for children and adolescents with Long COVID as well as the work of the expert group on Long COVID Off-Label Use.
Following the round table, further information will be published here.